Stay updated on Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial
Sign up to get notified when there's something new on the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page.

Latest updates to the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. This appears to be an internal version change with no visible impact on study details.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedLocations section now lists study sites by state (Alabama, California, Massachusetts, North Carolina, Ohio, Texas, Washington). The page revision has been updated to v3.3.3 (replacing v3.3.2).SummaryDifference0.8%

- Check53 days agoChange DetectedThe Publications section wording was updated to indicate that publications are automatically filled from PubMed and the Revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the government funding/operating-status banner from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedThe Study Details page content, sections, and data appear unchanged across screenshots; no substantive updates to the study information or navigation are visible.SummaryDifference0.4%

- Check103 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 tag removed. Core content impacted by the new status information.SummaryDifference4%

Stay in the know with updates to Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evaluating Therapeutic HSV-2 Vaccine Formulation Clinical Trial page.